Drug makers jointly share informations about unfair trade acts.

The KPMA took a meeting of the Fair Trade Order Commission on April 10, and agreed that all member companies would jointly to share any informations about irrational drug trade deals transacted between drug suppliers and medical institutes in order to jointly counteract against such unfair trade attempts. to make an earlier settlement of the actual purchasing price reimbursement system for all ...